 |
British Medical Company Opens Subsidiary in Shanghai
Construction on a 34-million-US-dollar pharmaceutical factory, jointly funded by British medical sciences company Nycomed Amersham and two Chinese firms, began recently in Shanghai.
The Shanghai Nycomed Pharmaceutical Company, located in Shanghai's Zhangjiang High-Tech Industrial Park and scheduled for operation by the end of the year, is to produce five million bottles of contrast medium a year.
Nycomed Amersham owns 80 percent of the joint venture, with the Zhangjiang High-Tech Industrial Park Development Co. Ltd. and the Shanghai Huaihai Pharmaceutical Factory owning 13 percent and 7 percent, respectively.
Shanghai Nycomed products are to be sold in China and other Asian countries.
Nycomed Amersham leads the world in contrast medium production, with annual sales of 1.3 billion pounds.
In This Section
|